Back to Authors

Talley, Heather N.

Mayo Clinic

Mayo Clinic

Citations 2

Diagnostic Yield of REM Sleep Muscle Activity for Presumed Synucleinopathy Neurodegeneration (N7.001)
Feemster, John, Tabatabai, Grace, Sandness, David J., Timm, Paul, McCarter, Allison R., Talley, Heather N., Johnson, Katie L. , Savica, Rodolfo , Josephs, Keith A. , Boeve, Bradley, Silber, Michael H. , McCarter, Stuart J. , Vemuri, Prashanthi , Mielke, Michelle M. , Machulda, Mary M. , Kantarci, Kejal , Singer, Wolfgang , Coon, Elizabeth A. , Louis, Erik K. St.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.n7.001 Get It

Submentalis Rapid Eye Movement Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy
McCarter, Stuart J. , Feemster, John, Tabatabai, Grace, Sandness, David J., Timm, Paul, McCarter, Allison R., Talley, Heather N., Junna, Mithri R. , Savica, Rodolfo , Benarroch, Eduardo E. , Josephs, Keith A. , Silber, Michael H. , Louis, Erik K. St. , Feemster, John C, Tabatabai, Grace M, Timm, Paul C, St Louis, E K , McCarter, Stuart J , Singer, Wolfgang , Coon, Elizabeth A. , Boeve, Bradley F.

Annals of Neurology | October 17, 2019 | Volume: 86 | Issue: 6 | Pages: 969-974

10.1002/ana.25622 Get It

Accurate antemortem diagnosis of parkinsonism is primarily based on clinical evaluation with limited biomarkers. We evaluated the diagnostic utility of quantitative rapid eye movement (REM) sleep without atonia analysis in the submentalis and anterior tibialis muscles in parkinsonian patients (53 synucleinopathy, 24 tauopathy). Receiver operating characteristic curves determined REM sleep without atonia cutoffs distinguishing synucleinopathies from tauopathies. Elevated submentalis muscle activity was highly sensitive (70–77%) and specific (95–100%) in distinguishing synucleinopathy from tauopathy. In contrast, anterior tibialis synucleinopathy discrimination was poor. Our results suggest that elevated submentalis REM sleep without atonia appears to be a potentially useful biomarker for presumed synucleinopathy etiologies in parkinsonism. ANN NEUROL 2019;86:969–974